![](https://investorshub.advfn.com/uicon/479388.png?cb=1599729622)
Thursday, December 05, 2019 8:55:16 AM
Recent SAGE News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:57:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:16:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 10:45:00 AM
- Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease • Business Wire • 06/11/2024 10:30:00 AM
- Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/05/2024 10:30:00 AM
- Sage Therapeutics to Participate in Upcoming May Investor Conferences • Business Wire • 05/07/2024 10:30:00 AM
- Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress • Business Wire • 04/25/2024 10:30:00 AM
- Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease • Business Wire • 04/17/2024 10:30:00 AM
- Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024 • Business Wire • 04/11/2024 10:30:00 AM
- Sage Therapeutics to Present at Upcoming March Investor Conferences • Business Wire • 02/28/2024 11:30:00 AM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 02/21/2024 09:35:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:02:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:02:15 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:09:44 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/14/2024 12:49:08 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/14/2024 12:20:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 11:45:53 AM
- Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress • Business Wire • 02/14/2024 11:30:00 AM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 01/31/2024 10:25:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:50:55 PM
- Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024 • Business Wire • 01/31/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:10:55 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 01/23/2024 01:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 11:45:04 AM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM